TOP STORIES

• BUSINESS Kymriah OK’ed, Novartis Says It’s Not Up for Outcome-Based Pricing in Japan
  March 27, 2019

• BUSINESS Novartis Snags Japan Approval for CAR-T Therapy Kymriah
  March 26, 2019

• REGULATORY Nesp Biosame Likely to Be Priced at 70% of Originator as Stopgap Measure
  March 26, 2019

• INTERVIEW With HIV Back in Hand, Gilead Heading into Second Phase in Japan Market: Pres. Hermans
  March 26, 2019

• REGULATORY PMDA Chief Kondo to Step Down after 11 Years in Charge
  March 25, 2019

• REGULATORY LDP Lawmakers Not So Positive about Reflecting Societal Values to Drug Prices; They Don’t Know How
  March 22, 2019

• BUSINESS Biogen/Eisai’s Aducanumab Fails, Dashing Hopes in Alzheimer’s Field
  March 22, 2019

• BUSINESS Gilead Set to Duplicate Biktarvy Success in Japan with New Stand-Alone HIV Sales Force
  March 20, 2019

• BUSINESS Employee Sues Bayer Japan for Emotional Distress over Xarelto Scandal
  March 19, 2019

• ORGANIZATION Kenporen Director Kono: Apply CEA to Reimbursement Decisions Once Credible System Established
  March 18, 2019

• BUSINESS Drug Makers, Wholesalers Establishing Supervisory Divisions as Detailing Guidelines Rollout Nears
  March 15, 2019

• REGULATORY MHLW to Promote Master Protocol Trials to Boost Efficiency in New Drug Development
  March 14, 2019

• BUSINESS Fujifilm Going Full Throttle in CDMO Biz with Buyout of Biogen Unit
  March 13, 2019

• REGULATORY Detailing Guidelines Casting Clouds over Drug Maker-Sponsored Press Seminars?
  March 12, 2019

• BUSINESS Meiji Pharma Pursuing Low-Cost Strategy to Weather Storm in Generics Space, Overseas Plants Hold Key
  March 11, 2019

• BUSINESS Eisai CEO Says “20% ROE in 2025” within Reach If All 3 Alzheimer’s Candidates, Lenvima Deliver
  March 8, 2019

• INTERVIEW JMA Exec Matsumoto: CEA Scheme Merely a Supplemental Tool to Drug Pricing System, Continued Discussions Necessary
  March 7, 2019

• BUSINESS Pfizer Japan Logs 2.6% Growth in FY2018, No Job Cut Planned: Chief
  March 6, 2019

• TRENDS Drug Makers on Hunt for “Mibyo” Biz Opportunities as Pricing Rules Get Stricter
  March 5, 2019

• COMMENTARY Generic Makers Shifting to Focus on “Specialty Area” Faced with Tougher Business Environment
  March 4, 2019

ページ

• « 先頭
• ‹ Prev
• …
• 138
• 139
• 140
• 141
• 142
• 143
• 144
• 145
• 146
• …
• Next ›
• 最終 »